US Stock MarketDetailed Quotes
TVGN Tevogen Bio Holdings
- 2.530
- +0.070+2.85%
Close Oct 31 16:00 ET
- 2.520
- -0.010-0.40%
Post 16:17 ET
431.74MMarket Cap-31625P/E (TTM)
2.572High2.205Low5.47MVolume2.520Open2.460Pre Close13.29MTurnover39.30%Turnover RatioLossP/E (Static)170.65MShares21.09052wk High-41.48P/B35.24MFloat Cap0.25652wk Low--Dividend TTM13.93MShs Float21.090Historical High--Div YieldTTM14.93%Amplitude0.256Historical Low2.427Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Tevogen Bio Holdings Stock Forum
Top resistance has climbed up so we may get a noon run up
outflow is deopping as well
31/10/2024 - 22:54
Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen’s approach has the potential to shorten timelines and substantially reduce costs.
Tevogen’s AI initiative, Tevogen.AI, will pursue two key objectives, applying machine learning to existing p...
👋
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
Current timeline for drug development is 10-12 years and costs approximately $1-3 billion. Tevogen's approach has the potential to shorten timelines and substantially reduce costs.
Tevogen's AI initiative, Tevogen.AI, will pursue two key objectives, applying machine learning to existing processes to acce...
No comment yet